Newsroom | Earlham Institute

Could our immune system be why COVID-19 is so deadly?

Scientists at the Earlham Institute (EI) and the Quadram Institute study how the immune system responds to infection with SARS-CoV-2 and other similar respiratory viruses, in particular to identifying unique features in severely ill COVID-19 patients.

16 February 2021

ViralLink identifies key proteins in SARS-CoV-2-infected cells: workflow open to all

Bioinformatics researchers at the Earlham Institute (EI) and Quadram Institute (QIB) have today published a workflow to identify key proteins and interactions in cells infected with SARS-CoV-2.

Our research
- Research strategy
  - Our Culture
  - Open and FAIR Data
- Explore our research
  - Research projects
  - Publications
- Our research programmes
- National Bioscience Research Infrastructures
  - Earlham Biofoundry
  - Transformative Genomics
- Scientific Groups
Technology platforms
Training and events
Stories and impact
About
People
- Staff
Careers
Contact